Anaxomics maps have been presented in the cover page of the November issue of Nature Chemical Biology

Home > Strategic Alliances > Biomarkers Discovery

Biomarkers Discovery


New developments in genomics, transcriptomics and metabolomics are increasing the amount of data available for analysis from the biomarkers perspective.

Altough a number of signals can be detected as increased / decreased expression levels of a pool of proteins, if we are not able to put those signals in biological context, their usefulness can be severely impaired.

A systems biology and protein network approach allows to put those signals into biological context, and allows to evaluate their real value as disease, diagnostic or pronostic biomarkers.


Anaxomics collaborates with companies specialized in proteomics, transcriptomics and metabolomics in order to offer the best rational approach to biomarkers discovery.


Biomarker Clustering Analysis Picture
Icon Home Icon Sitemap Icon Pdf Icon Mail
  • Business cases

    Read our business cases to understand how Anaxomics can really help you add value to your discovery

  • dotted line
  • News

    Anaxomics has been awarded from the
    VII Framework Programme EU.
    Gums&Joints Project
    November 2010

    Anaxomics to present at the BIO EUROPE in Munich November 15-17

    Anaxomics to present at The International Nutraceutical Conference in Milan October 26-28

  • dotted line
  • Contact

    Judith Farrés
    PhD, MSc
    info@anaxomics.com
    Phone:
    +34 93 451 67 17
    Cell:
    +34 610 742 196

  • dotted line
  • Careers

    Anaxomics offers positions for professionals who would like to work for a cutting-edge consultancy firm in a multinational environment.